Double attack on tough cervical cancers
NCT ID NCT03614949
Summary
This study is testing whether combining a precise, high-dose radiation treatment (SBRT) with an immunotherapy drug (atezolizumab) works better than the drug alone for cervical cancer that has returned or spread. It involves about 21 women with advanced cervical cancer. The goal is to see if the combination helps shrink tumors more effectively and for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
Ohio State University - OSUMC - Wexner Medical Center
Hilliard, Ohio, 43026, United States
Conditions
Explore the condition pages connected to this study.